Kymera Therapeutics, Inc.

KYMR

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001193125-26-091986
Filing date: Mar 4, 2026
Earliest execution date: Mar 2, 2026

Summary

Type

Neutral

Net shares

+4,125

% of shares

7.86%

Amount (USD)

$0

Insider confidence score

85.0 out of 100

Positive

  • Huge buy (≥5% of shares)

Negative

  • Minimal buy amount (<$10K)

Stock transactions

Transaction 1

Security

Common Stock

Action

Grant

Date

2026-03-02

Code

A

Net shares

+4,125.0

Acquired/Disposed

Acquired

Shares Owned Before

52,500.0

Shares Owned After

56,625.0

Derivative Transactions

Transaction 1

Security

Stock Option (Right to Buy)

Action

Grant

Date

2026-03-02

Code

A

Net shares

+8,250.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

8,250.0

Filing's footnotes

1. Represents restricted stock units (&quot;RSUs&quot;). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following March 2, 2026, subject to the reporting person's continued employment through each vesting date.

2. The shares underlying this stock option shall vest in fourty-eight (48) equal monthly installments following March 2, 2026, subject to the reporting person's continued employment through each vesting date.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.